Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-10
1989-02-14
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548321, A61K 31415
Patent
active
048046728
ABSTRACT:
Novel agent for the treatment of kidney diseases, which comprises as an active ingredient a 2-oxo-imidazolidine compound of the formula: ##STR1## wherein R.sup.1 is a lower alkyl group, R.sup.2 is a lower alkyl group, R.sup.3 is a phenyl-substituted lower alkyl group, and R.sup.4 is hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof.
REFERENCES:
Chemical Abstracts, 100:174,827y (1984) [EP 95,163, Yoneda et al., 11/30/83].
Chemical Abstracts, 103:116,288z (1985) [Japan Kokai, 60 13,715, 1/24/85].
McCaa, R., in Frontiers in Hypertension Research, Laragh, J. et al., (editors), Springer-Verlag, New York, 1981, pp. 139-140.
Kubo Masami
Nishiyama Shinsuke
Yamaguchi Isao
Schwartz Richard A.
Tanabe Seiyaku Co. Ltd.
LandOfFree
2-oxo-imidazolidine derivatives as agents for treatment of kidne does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-oxo-imidazolidine derivatives as agents for treatment of kidne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-oxo-imidazolidine derivatives as agents for treatment of kidne will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1365893